Specialization
Donor Medicine
Amsterdam Public Health
-
Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial
van der Kraaij, G., Busard, C., van den Reek, J., Menting, S., Musters, A., Hutten, B., de Rie, M., Ouwerkerk, W., van Bezooijen, S-J., Prens, E., Rispens, T., de Vries, A., de Jong, E., de Kort, W., Lambert, J., van Doorn, M. & Spuls, P., Sept 2022, In: Journal of Investigative Dermatology. 142, 9, p. 2375-2383.e6Research output: Contribution to journal › Article › Academic › peer-review
-
Genetic determinants of ferritin, haemoglobin levels and haemoglobin trajectories: results from Donor InSight
Timmer, T., Tanck, M., Penkett, C., Stirrups, K., Gleadall, N., de Kort, W., van der Schoot, E. & van den Hurk, K., 1 Aug 2021, In: Vox sanguinis. 116, 7, p. 755-765 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Online decision aid for patients with psoriasis
van der Kraaij, G. E., van Huizen, A. M., Baerveldt, E. M., Boshuizen, M., Determann, D., van Ee, I., Hageman, M., de Kort, W., Tafuni, G., Smeets, P. M. G. & Spuls, P. I., May 2021, In: British Journal of Dermatology. 184, 5, p. 981-983 3 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications